Small molecule · developed by Rising
Azelastine is a nasal spray formulation of azelastine hydrochloride, given at 137 µg twice daily in each nostril in combination with fluticasone propionate. It is studied in seasonal allergic rhinitis and allergic rhinitis due to allergens.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07597473 | Phase 4 | Allergic Rhinitis Due to Allergens | Completed | VTRS |
| NCT00940953 | Phase 2 | Seasonal Allergic Rhinitis | Completed | LGND |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Allergic Rhinitis Due to AllergensSeasonal Allergic Rhinitis